Related Experiment Video
Updated: Sep 6, 2025

Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
Multivalent γ-PGA-Exendin-4 Conjugates to Target Pancreatic β-Cells
Lorenzo Rossi1, Krisztina Kerekes2, Judit Kovács-Kocsi2
1Department of Biotechnology ad Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 20126, Milan, Italy.
Researchers created a more effective GLP-1R ligand by conjugating exendin-4 to poly-γ-glutamic acid. This new compound shows double the affinity for the glucagon-like peptide 1 receptor, improving diabetes treatments and diagnostics.
Area of Science:
- Bioconjugation Chemistry
- Medicinal Chemistry
- Endocrinology
Background:
- Glucagon-like peptide 1 receptor (GLP-1R) is a key target for diabetes therapy and insulinoma diagnostics.
- Exendin-4 (Ex-4) is an approved type 2 diabetes drug that targets GLP-1R.
- Developing more stable and effective GLP-1R ligands is crucial for advanced therapeutic and diagnostic applications.
Purpose of the Study:
- To conjugate exendin-4 (Ex-4) to poly-γ-glutamic acid (γ-PGA) to create novel GLP-1R ligands.
- To enhance the stability and efficacy of GLP-1R targeting agents.
- To explore improved therapeutic and diagnostic strategies for diabetes and insulinoma.
Main Methods:
- Exendin-4 was modified at Lysine-27 with PEG4-maleimide.
- Modified Ex-4 was conjugated to furan-functionalized γ-PGA using Diels-Alder cycloaddition.
- Different molar ratios of Ex-4 to γ-PGA were investigated.
Main Results:
- A conjugate with an average of 120 Ex-4 molecules per γ-PGA chain was synthesized.
- This high-density conjugate exhibited double the affinity for GLP-1R compared to exendin-4 alone.
- The conjugation strategy successfully yielded a more potent GLP-1R ligand.
Conclusions:
- The developed Ex-4-γ-PGA conjugate represents a promising advancement in GLP-1R ligand design.
- Enhanced GLP-1R affinity suggests improved potential for diabetes treatment and insulinoma diagnosis.
- This approach offers a viable route for creating next-generation therapeutic and diagnostic agents.
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

